Episode 410: AUA 2025 - BOND-003 Cohort C: Crestimogene in BCG-Unresponsive NMIBC

By The Uromigos - Last Updated: April 27, 2025

Dr. Mark Tyson from Mayo Clinic joins the podcast to discuss this replicating adenovirus and a high CR rate in BCG-unresponsive NMIBC.

Post Tags:Uromigos-Bladder Cancer

Related Podcasts

Episode 409: AUA 2025 - CREST - BCG +/- Sasanlimab in High-Risk NMIBC

Uromigos-Bladder Cancer

Episode 407: Drug Development in China: Part 2 of 2

Episode 406: Drug Development in China: Part 1 of 2

Episode 405: The Good News About Cancer Podcast

Episode 404: 177 Lu-PSMA Pre-Chemotherapy in mCRPC

Uromigos-Prostate Cancer

Advertisement

Advertisement